Cite
HARVARD Citation
Fabi, A. et al. (2016). First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?. Journal of experimental & clinical cancer research. 35 (1), pp. 1-11. [Online].